Our History
The EPS Group continues to expand
The EPS Group’s history dates back to 1991, when it began as a software development company. Since then, we have steadily expanded our business from CRO, SMO, to CSO, and we are developing various businesses in China and the Asia-Pacific. This section highlights and traces the changes in the EPS Group.
E.P.S. Tokyo, Co., Ltd. was started with three employees, focusing on the development of “systems to manage treatment allocation and trial progress” and “GCP management systems” to manage clinical trials scientifically and ethically.
We were contracted to develop a support system for two large-scale clinical trials (the “MEGA Study” and the “ATHEROMA Study”) as part of the Ministry of Health and Welfare’s drug epidemiology research. In addition, data center operations have begun for both studies.
1996
Company name changed to EPS Co., Ltd.
1999
We started operations in Shanghai as the first full-fledged contract research organization (CRO) in China.
We started our SMO business to support clinical trial-related operations of medical institutions. Since then, through several mergers, the EPS Group’s SMO business has grown to hold the No. 1 market share in the industry.
2000
Started CSO (Contract Sales Organization) business, which undertakes MR (Medical Representative) operations for pharmaceutical companies.
2001
We became the first CRO to go public.
EPS Corporation listed on JASDAQ.
EPS Corporation listed on the 1st section of the Tokyo Stock Exchange.
Started Pharmaceutical products sales business in China.
Transferred to a holding company system and changed the company name to EPS Holdings, Inc.
TSUKUDO TERRACE, our own building was completed